147 related articles for article (PubMed ID: 26393572)
1. Protective Effects of MDG-1, a Polysaccharide from Ophiopogon japonicus on Diabetic Nephropathy in Diabetic KKAy Mice.
Wang Y; Shi LL; Wang LY; Xu JW; Feng Y
Int J Mol Sci; 2015 Sep; 16(9):22473-84. PubMed ID: 26393572
[TBL] [Abstract][Full Text] [Related]
2. MDG-1, a polysaccharide from Ophiopogon japonicus exerts hypoglycemic effects through the PI3K/Akt pathway in a diabetic KKAy mouse model.
Wang LY; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
J Ethnopharmacol; 2012 Aug; 143(1):347-54. PubMed ID: 22776833
[TBL] [Abstract][Full Text] [Related]
3. Fecal metabonomic study of a polysaccharide, MDG-1 from Ophiopogon japonicus on diabetic mice based on gas chromatography/time-of-flight mass spectrometry (GC TOF/MS).
Zhu Y; Cong W; Shen L; Wei H; Wang Y; Wang L; Ruan K; Wu F; Feng Y
Mol Biosyst; 2014 Feb; 10(2):304-12. PubMed ID: 24292023
[TBL] [Abstract][Full Text] [Related]
4. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside effect on TGF-β1, SMAD2/3, and α-SMA expression in the kidney tissues of diabetic KKAy mice.
Wang Y; Lin C; Ren Q; Liu Y; Yang X
Int J Clin Exp Pathol; 2015; 8(6):6828-34. PubMed ID: 26261569
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of oxymatrine on experimental diabetic nephropathy.
Guo C; Han F; Zhang C; Xiao W; Yang Z
Planta Med; 2014 Mar; 80(4):269-76. PubMed ID: 24535719
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of the polysaccharide from Ophiopogon japonicus on streptozotocin-induced diabetic rats.
Chen X; Tang J; Xie W; Wang J; Jin J; Ren J; Jin L; Lu J
Carbohydr Polym; 2013 Apr; 94(1):378-85. PubMed ID: 23544552
[TBL] [Abstract][Full Text] [Related]
8. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of diabetic nephropathy by Chaihuang-Yishen granule through anti-inflammatory mechanism in streptozotocin-induced rat model of diabetics.
Zhang H; Zhao T; Gong Y; Dong X; Zhang W; Sun S; Wang H; Gu Y; Lu X; Yan M; Li P
J Ethnopharmacol; 2014; 151(1):556-64. PubMed ID: 24269779
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the TGFβ1- ILK-Akt signaling pathway in the effects of hesperidin in type 2 diabetic nephropathy.
Zhang Y; Wang B; Guo F; Li Z; Qin G
Biomed Pharmacother; 2018 Sep; 105():766-772. PubMed ID: 29909344
[TBL] [Abstract][Full Text] [Related]
11. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
Liu IM; Tzeng TF; Liou SS; Chang CJ
J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
[TBL] [Abstract][Full Text] [Related]
12. Bergenin ameliorates diabetic nephropathy in rats via suppressing renal inflammation and TGF-β1-Smads pathway.
Yang J; Kan M; Wu GY
Immunopharmacol Immunotoxicol; 2016; 38(2):145-52. PubMed ID: 26954391
[TBL] [Abstract][Full Text] [Related]
13. The Ethyl Acetate Extract of
Lin CH; Shih CC
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928391
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of Icariin on the early stage of experimental diabetic nephropathy induced by streptozotocin via modulating transforming growth factor β1 and type IV collagen expression in rats.
Qi MY; Kai-Chen ; Liu HR; Su YH; Yu SQ
J Ethnopharmacol; 2011 Dec; 138(3):731-6. PubMed ID: 22027446
[TBL] [Abstract][Full Text] [Related]
15. Reduced beta 2 glycoprotein I improves diabetic nephropathy via inhibiting TGF-β1-p38 MAPK pathway.
Wang T; Chen SS; Chen R; Yu DM; Yu P
Int J Clin Exp Pathol; 2015; 8(3):2321-33. PubMed ID: 26045739
[TBL] [Abstract][Full Text] [Related]
16. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
17. Skimmin, a coumarin, suppresses the streptozotocin-induced diabetic nephropathy in wistar rats.
Zhang S; Yang J; Li H; Li Y; Liu Y; Zhang D; Zhang F; Zhou W; Chen X
Eur J Pharmacol; 2012 Oct; 692(1-3):78-83. PubMed ID: 22664227
[TBL] [Abstract][Full Text] [Related]
18. Fucoidan exerts protective effects against diabetic nephropathy related to spontaneous diabetes through the NF-κB signaling pathway in vivo and in vitro.
Wang Y; Nie M; Lu Y; Wang R; Li J; Yang B; Xia M; Zhang H; Li X
Int J Mol Med; 2015 Apr; 35(4):1067-73. PubMed ID: 25672488
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes.
Lin Y; Sun Z
J Endocrinol; 2011 May; 209(2):185-91. PubMed ID: 21307121
[TBL] [Abstract][Full Text] [Related]
20. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.
Alhaider AA; Korashy HM; Sayed-Ahmed MM; Mobark M; Kfoury H; Mansour MA
Chem Biol Interact; 2011 Jul; 192(3):233-42. PubMed ID: 21457706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
